TRACY OELLER: Open Payments
NPI 1053490425 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,678 in 98 payments from 21 companies in 2025. Trend: 2023 $1,550 · 2024 $1,798 · 2025 $1,678
Food & beverage: $1,678
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $278 |
| Lilly USA, LLC | 14 | $218 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $195 |
| ABBVIE INC. | 14 | $183 |
| AstraZeneca Pharmaceuticals LP | 2 | $141 |
| PFIZER INC. | 6 | $110 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Dexcom, Inc. | 4 | $71 |
| Astellas Pharma US Inc | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
Products named: JARDIANCE, MOUNJARO, AIRSUPRA, Ozempic, Rybelsus, NURTEC ODT, Dexcom G6 Transmitter, Veozah.
Industry payments across TX — which companies pay providers there.
